Tender Details

Country: Brazil
Summary: Acquisition of Oncological Medications. (Process: 25410.011034/2023-23)
BRT Ref No: 99072509
Deadline: 01 Apr 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 91018/2024
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Object: Electronic Auction - Acquisition of Oncological Medicines. (PROCESS: 25410.011034/2023-23)
UASG Code: 250052
Notice from: 03/19/2024 from 09:00 to 16:00
Proposal Delivery: from 03/19/2024 at 09 :00Hs
CETUXIMAB, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM INJ SOLUTION19981d172c851bd4e8a1788d5726c2d3ETABLE
Quantity: 5340
ERLOTINIB, DOSAGE 150 MG
Quantity: 7900
GEFITINIB, CONCENTRATION 250 MG
Quantity: 11549
GOSERELLIN ACETATE, DOSAGE 10.80 MG, INJECTABLE SOLUTION INDICATION
Quantity: 4737
GOSERELIN ACETATE, DOSAGE 3.6 MG, INJECTABLE SOLUTION INDICATION
Quantity: 1022
LANREOTID19981d172c851bd4e8a1788d5726c2d3ACETATE, CONCENTRATION 120 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS PROLONGED RELEASE
Quantity: 1828
LEUPRORELIN ACETATE, CONCENTRATION 22.5 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 4674
LEU PRORRELLIN ACETATE, CONCENTRATION 3, 75 MG, FARM FORM19981d172c851bd4e8a1788d5726c2d3ACEUTICA LYOPHIL POWDER FOR INJECTABLE
Quantity: 750
OCTREOTIDE, ACETATE SALT COMPOSITION, CONCENTRATION 20 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE, ADDITIONAL CHARACTERISTICS WITH APPLICATION SYSTEM
Quantity: 2135
PANITUMOMAB, CONCENTRATION 20 MG/ ML, SHAPE PHARMACEUTICAL INJECTABLE SOLUTION
Quantity19981d172c851bd4e8a1788d5726c2d3and: 3521
PEMBROLIZUMABE, CONCENTRATION 25 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 1428
TRIPTORRELIN, COMPOSITION SALT EMBONATO, CONCENTRATION 11.25 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 1950
TRIPTORRE LINA, ACETATE SALT COMPOSITION , CONCENTRATION 3.75 MG/ML, FAR FORM19981d172c851bd4e8a1788d5726c2d3MACEUTICA INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS FILLED SYRINGE, PROLONGED RELEASE
Quantity: 750
TRIPTORRELIN, COMPOSITION SALT EMBONATO, CONCENTRATION 3.75 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 750
NIVOLUMAB, CONCENTRATION 10 MG/ML, PHARMACEUTICAL FORM INJ SOLUTION19981d172c851bd4e8a1788d5726c2d3ETABLE
Quantity: 235
NIVOLUMAB, CONCENTRATION 10 MG/ML, FORM...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Acquisition of Oncological Medications. (Process: 25410.011034/2023-23) - Brazil Tender

The MINISTRY OF HEALTH, a Government sector organization in Brazil, has announced a new tender for Acquisition of Oncological Medications. (Process: 25410.011034/2023-23). This tender is published on BrazilTenders under BRT Ref No: 99072509 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-04-01.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.